![]() |
Name |
Furaquinocin D
|
Molecular Formula | C22H26O6 | |
IUPAC Name* |
(2R,3S)-4-hydroxy-3-[(1R)-1-hydroxy-4-methylpent-3-enyl]-7-methoxy-2,3,8-trimethyl-2H-benzo[g][1]benzofuran-6,9-dione
|
|
SMILES |
C[C@@H]1[C@](C2=C(C=C3C(=C2O1)C(=O)C(=C(C3=O)OC)C)O)(C)[C@@H](CC=C(C)C)O
|
|
InChI |
InChI=1S/C22H26O6/c1-10(2)7-8-15(24)22(5)12(4)28-21-16-13(9-14(23)17(21)22)19(26)20(27-6)11(3)18(16)25/h7,9,12,15,23-24H,8H2,1-6H3/t12-,15-,22-/m1/s1
|
|
InChIKey |
HVPDKSONVUABMQ-AVKZDSLQSA-N
|
|
Synonyms |
Furaquinocin D; Q44258402; (2R,3S)-4-hydroxy-3-[(1R)-1-hydroxy-4-methylpent-3-enyl]-7-methoxy-2,3,8-trimethyl-2H-benzo[g][1]benzofuran-6,9-dione
|
|
CAS | NA | |
PubChem CID | 11079568 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 386.4 | ALogp: | 3.8 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 93.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 28 | QED Weighted: | 0.754 |
Caco-2 Permeability: | -4.841 | MDCK Permeability: | 0.00001400 |
Pgp-inhibitor: | 0.904 | Pgp-substrate: | 0.437 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.016 |
Blood-Brain-Barrier Penetration (BBB): | 0.054 | Plasma Protein Binding (PPB): | 83.91% |
Volume Distribution (VD): | 0.988 | Fu: | 9.90% |
CYP1A2-inhibitor: | 0.919 | CYP1A2-substrate: | 0.673 |
CYP2C19-inhibitor: | 0.914 | CYP2C19-substrate: | 0.266 |
CYP2C9-inhibitor: | 0.87 | CYP2C9-substrate: | 0.672 |
CYP2D6-inhibitor: | 0.936 | CYP2D6-substrate: | 0.085 |
CYP3A4-inhibitor: | 0.69 | CYP3A4-substrate: | 0.217 |
Clearance (CL): | 10.25 | Half-life (T1/2): | 0.076 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.767 |
Drug-inuced Liver Injury (DILI): | 0.126 | AMES Toxicity: | 0.093 |
Rat Oral Acute Toxicity: | 0.704 | Maximum Recommended Daily Dose: | 0.771 |
Skin Sensitization: | 0.29 | Carcinogencity: | 0.117 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.057 |
Respiratory Toxicity: | 0.67 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002147 | ![]() |
0.841 | D0Q0PR | ![]() |
0.253 | ||
ENC002784 | ![]() |
0.821 | D0B9EJ | ![]() |
0.246 | ||
ENC005156 | ![]() |
0.380 | D0C1SF | ![]() |
0.241 | ||
ENC003047 | ![]() |
0.378 | D0WY9N | ![]() |
0.237 | ||
ENC005159 | ![]() |
0.366 | D01XWG | ![]() |
0.229 | ||
ENC005551 | ![]() |
0.358 | D0N1FS | ![]() |
0.225 | ||
ENC006089 | ![]() |
0.358 | D0FX2Q | ![]() |
0.218 | ||
ENC003531 | ![]() |
0.347 | D07VLY | ![]() |
0.216 | ||
ENC003141 | ![]() |
0.333 | D07MGA | ![]() |
0.216 | ||
ENC003962 | ![]() |
0.333 | D0C9XJ | ![]() |
0.216 |